Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PPARγ-IN-3
Cat. No.:
OB0425LY-225
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
PPARγ-IN-3 is a selective PPARγ (peroxisome proliferator-activated receptor gamma) inhibitor for the regulation of glucolipid metabolism.
Synonyms:
PPARγ-IN-3; PPARγ inhibitor 3
Formula:
C23H28FN7O3
Formula Weight:
469.51
Specification
Target:
PPAR
Pathway:
Cell cycle/DNA damage; Metabolic enzyme/Protease; Vitamin D related/Nuclear receptor
Storage:
Storage at -20°C.
Applications:
PPARγ-IN-3 is commonly used in diabetes, cardiovascular disease and obesity related studies to help explore the function and mechanism of PPARγ in metabolic diseases.
